Anika Therapeutics (ANIK) Other Gross PP&E Adjustments (2016 - 2025)
Anika Therapeutics (ANIK) has disclosed Other Gross PP&E Adjustments for 16 consecutive years, with $64.0 million as the latest value for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 14.96% to $64.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $64.0 million, a 14.96% increase, with the full-year FY2025 number at $64.0 million, up 14.96% from a year prior.
- Other Gross PP&E Adjustments was $64.0 million for Q4 2025 at Anika Therapeutics, up from -$26.0 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $65.1 million in Q2 2025 to a low of -$34.8 million in Q2 2022.
- A 5-year average of $2.1 million and a median of -$24.4 million in 2021 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: plummeted 59.13% in 2022, then soared 328.91% in 2025.
- Anika Therapeutics' Other Gross PP&E Adjustments stood at $62.6 million in 2021, then dropped by 3.22% to $60.6 million in 2022, then dropped by 14.87% to $51.6 million in 2023, then increased by 7.91% to $55.7 million in 2024, then grew by 14.96% to $64.0 million in 2025.
- Per Business Quant, the three most recent readings for ANIK's Other Gross PP&E Adjustments are $64.0 million (Q4 2025), -$26.0 million (Q3 2025), and $65.1 million (Q2 2025).